Records containing: Psoriasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-04-05Role of HLA and KIR in the Natural History of Psoriasis
-
CLINICAL_TRIALS study record update · 2018-04-03A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2018-04-02Revitalization of Damaged Sking Due to Chronic Skin Diseases
-
CLINICAL_TRIALS study record update · 2018-03-30Estimation of Tissue Level of Resolvin D1 in Psoriasis Before and After Narrowband UVB Phototherapy: a Case-control Study.
-
CLINICAL_TRIALS study record update · 2018-03-27A Phase 1b Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study Assessing the PK, Pharmacodynamics, Safety, and Tolerability of SB414 in Subjects With Psoriasis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-03-23Characterization of Cutaneous Microbiota and Evaluation of the Antimicrobial Peptides Roles in the Psoriasis Etiopathogenesis
-
CLINICAL_TRIALS study record update · 2018-03-23A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Ixekizumab Versus Placebo in Patients With Moderate-to-Severe Genital Psoriasis
-
CLINICAL_TRIALS study record update · 2018-03-20A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Efalizumab in the Treatment of Adult Patients With Moderate to Severe Chronic Plaque Psoriasis Who Have Failed to Respond to, or Who Have a Contraindication to, or Are Intolerant to Other Systemic Therapies Including Ciclosporin, Methotrexate and PUVA
-
CLINICAL_TRIALS study record update · 2018-03-19Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study
-
CLINICAL_TRIALS study record update · 2018-03-14Phase 1 Clinical Trial to Evaluate the Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis.
-
CLINICAL_TRIALS study record update · 2018-03-07Randomized, Double Blind, Placebo Controlled, Incomplete Crossover Single Oral Dose Escalation of PRCL-02 in Normal Healthy Volunteers (Part A) and Multiple Oral Dose Escalation in Normal Healthy Volunteers (Part B) and in Chronic Plaque Psoriasis Patients (Part C)
-
CLINICAL_TRIALS study record update · 2018-03-06Identification of New Prognostic Markers in Psoriatic Arthritis
-
CLINICAL_TRIALS study record update · 2018-03-05Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2018-03-02ClinicalTrials.gov study NCT00004468
-
CLINICAL_TRIALS study record update · 2018-03-02A Phase I, Partially-randomised, Partially Double-blinded, Safety, Tolerability and Pharmacokinetic Study of ABY-035 in Healthy Subjects and Psoriasis Patients
-
CLINICAL_TRIALS study record update · 2018-02-19Efficiency of a Nurse-led Individualized Educational Intervention in Newly Referred Patients With Psoriasis. A Pragmatic Controlled Study.
-
CLINICAL_TRIALS study record update · 2018-02-19ClinicalTrials.gov study NCT02382081
-
CLINICAL_TRIALS study record update · 2018-02-12Evaluation of Adipokines and Fat Tissue in Psoriasis and Psoriatic Arthritis and Assessment of Their Relations With the Risk of Cardiovascular Disease
-
CLINICAL_TRIALS study record update · 2018-02-12Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants
-
CLINICAL_TRIALS study record update · 2018-01-29A Randomized, Evaluator-Blind, Placebo-Controlled, Parallel-Group Dose-Ranging Study of the Safety and Efficacy of Oral R115866 and R115866 Placebo in the Treatment of Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2018-01-16A 28-day, Double-blind, Randomized, Reference-controlled Open Psoriasis Plaque Test for Within Subject Comparison of Efficacy and Safety of Mapracorat 0.1% Ointment and 4 Reference Products in Symptomatic Volunteers With Stable Plaque-type Psoriasis
-
CLINICAL_TRIALS study record update · 2018-01-03An Open-Label, Study Evaluating Enstilar® (Calcipotriene and Betamethasone Dipropionate) Foam, 0.005%/0.064% QD in Psoriasis Patients Being Treated With Biologic Agents
-
CLINICAL_TRIALS study record update · 2017-12-07A Double-Blind Safety and Efficacy Study of GSK2894512 Cream Versus Vehicle in the Treatment of Adult Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2017-11-29A Randomized, Double-Blind, Vehicle-Controlled, 3-Period, Sequential Study to Evaluate Pharmacokinetics, Safety and Tolerability of Single and Repeat Topical Applications of GSK2894512 Cream in Healthy Adult Participants
-
CLINICAL_TRIALS study record update · 2017-11-14A Phase I, Randomized, Double-blind, Placebo-controlled, Single Dose Escalation Study to Investigate Safety and Pharmacokinetics of SHR-1314 in Healthy Subjects